These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 5294537

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
    Flähmig M, Sieg U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Case contribution to the therapy of obstetrical afibrinogenemia].
    Pleissner K.
    Z Arztl Fortbild (Jena); 1967 Dec 15; 61(24):1297-9. PubMed ID: 5591403
    [No Abstract] [Full Text] [Related]

  • 5. [Defibrination syndrome in pregnancy. (Report on 7 cases at the Innsbruck University Gynecologic Clinic from 1962 to 1968)].
    Kalkschmid W, Holzknecht F.
    Wien Med Wochenschr; 1970 Jul 04; 120(27):508-11. PubMed ID: 5314308
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Successful treatment of a severe afibrinogenemia by combined use of various antifibrinolytic substances].
    Wille P.
    Geburtshilfe Frauenheilkd; 1965 Jul 04; 25(7):626-31. PubMed ID: 5297957
    [No Abstract] [Full Text] [Related]

  • 8. [Fibrinolytic problems in obstetrics].
    Doichinov A, Glavanakova V.
    Akush Ginekol (Sofiia); 1967 Jul 04; 6(3):218-28. PubMed ID: 4880476
    [No Abstract] [Full Text] [Related]

  • 9. [Antifibrinolytic agents and their therapeutic use].
    Fischer M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Jul 04; 92(1):64-77. PubMed ID: 4189375
    [No Abstract] [Full Text] [Related]

  • 10. Disseminated intravascular coagulation: a paradox of thrombosis and hemorrhage. Significance in obstetrics and gynecology. A review.
    Dixon RE.
    Obstet Gynecol Surv; 1973 Jun 04; 28(6):385-95. PubMed ID: 4614153
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hemorrhagic complications caused by coagulation disorders in retention of the dead fetus].
    Avanzini S, Orrù A, Malacrida V.
    Minerva Ginecol; 1969 Apr 30; 21(8):476-86. PubMed ID: 5306033
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Indications for antifibrinolytic therapy.
    Prentice CR.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):634-43. PubMed ID: 1108280
    [No Abstract] [Full Text] [Related]

  • 18. Indications and rationale for the use of proteinase inhibitors in obstetrics.
    Beller FK, Epstein MD.
    Ann N Y Acad Sci; 1968 Jun 28; 146(2):673-81. PubMed ID: 5306291
    [No Abstract] [Full Text] [Related]

  • 19. [Hyperfibrinolysis].
    Marx R, Matis P.
    Hoppe Seylers Z Physiol Chem; 1968 Jul 28; 349(7):934-5. PubMed ID: 5303675
    [No Abstract] [Full Text] [Related]

  • 20. [Fundamentals and therapy of acute coagulation disorders in obstetrics and surgery. Indication and contraindication in application of enzyme inhibitors].
    Steichele DF, Herschlein HJ.
    Med Welt; 1967 Aug 26; 34():1931-9. PubMed ID: 5300117
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.